Positive Data on Bayer/Regeneron’s Eye Drug – Analyst Blog
Bayer ( BAYRY ) along with partner, Regeneron Pharmaceuticals Inc. ( REGN ) recently announced positive 52 week data from …read more
Bayer ( BAYRY ) along with partner, Regeneron Pharmaceuticals Inc. ( REGN ) recently announced positive 52 week data from …read more
One of the leading U.S. homebuilding companies, KB Home ( KBH ) unveiled four communities in the Inland Empire region …read more
Sun Life Financial Inc. ( SLF ) has announced that it has successfully concluded the sale of some its U.S. …read more
On Aug 3, Zacks Investment Research upgraded Provident Financial Holdings, Inc. ( PROV ) to a Zacks Rank #1 (Strong …read more
Leading passenger airline JetBlue Airways Corporation ( JBLU ) will offer lie flat seats on flights between New York and …read more
We have retained our Neutral recommendation on H&R Block Inc . ( HRB ) as it reported a mixed fourth …read more
GlaxoSmithKline ( GSK ) recently announced that the decision on the approval of its diabetes candidate, albiglutide, from the U.S. …read more
NVIDIA Corp. ( NVDA ) is slated to report its second quarter 2014 results on Aug 8, 2013. Let’s see …read more
In a continuous effort to grow its mobile money transfer service facility Western Union Co. ( WU ) has entered …read more
Pacira Pharmaceuticals, Inc. ( PCRX ) recently announced disappointing data from its second pivotal phase III study on Exparel. The …read more